Back to MW Marshall Wace, LLP
RIGL
6 quarters
Position history for MWMarshall Wace, LLP's holdings in Rigel Pharmaceuticals, Inc.
Yes. Marshall Wace holds 367,393 shares of RIGL (Rigel Pharmaceuticals), worth $14.4M, as of its Q2 2026 13F filing. It reduced the position by 230,985 shares (-38.6%) from Q1 2026. Marshall Wace has held RIGL since Q1 2025, across 6 quarterly 13F filings.
Current Value
$14.4M
Current Shares
367,393
Total Value Change
+$10.6M
Total Shares Change
+155,645
Quarter-by-Quarter History
Other major holders of RIGL: BlackRock, Inc., State Street Corp.